View Item 

Show simple item record

Impact of MELD‐Based Allocation on End‐Stage Renal Disease After Liver Transplantation
dc.contributor.authorSharma, P.en_US
dc.contributor.authorSchaubel, Douglas E.en_US
dc.contributor.authorGuidinger, Mary K.en_US
dc.contributor.authorGoodrich, Nathan P.en_US
dc.contributor.authorOjo, Akinlolu O.en_US
dc.contributor.authorMerion, Robert M.en_US
dc.date.accessioned2011-12-05T18:35:30Z
dc.date.available2013-01-02T16:33:10Zen_US
dc.date.issued2011-11en_US
dc.identifier.citationSharma, P.; Schaubel, D. E.; Guidinger, M. K.; Goodrich, N. P.; Ojo, A. O.; Merion, R. M. (2011). "Impact of MELD‐Based Allocation on End‐Stage Renal Disease After Liver Transplantation." American Journal of Transplantation 11(11). <http://hdl.handle.net/2027.42/88114>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/88114
dc.publisherBlackwell Publishing Incen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherEnd‐Stage Renal Diseaseen_US
dc.subject.otherLiver Transplanten_US
dc.subject.otherModel for End‐Stage Renal Diseaseen_US
dc.subject.otherMortalityen_US
dc.subject.otherScientific Registry of Transplant Recipientsen_US
dc.titleImpact of MELD‐Based Allocation on End‐Stage Renal Disease After Liver Transplantationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biostatistics, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDepartment of Internal Medicineen_US
dc.contributor.affiliationotherArbor Research Collaborative for Health, Ann Arbor, MIen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/88114/1/j.1600-6143.2011.03703.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2011.03703.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceOjo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931 – 940.en_US
dc.identifier.citedreferenceSharma P, Schaubel DE, Sima CS, Merion RM, Lok AS. Re‐weighting the model for end‐stage liver disease score components. Gastroenterology 2008; 135: 1575 – 1581.en_US
dc.identifier.citedreferenceGonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transplant 2006; 6: 2651 – 2659.en_US
dc.identifier.citedreferenceSharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS. Renal outcomes after liver transplantation in the model for end‐stage liver disease era. Liver Transpl 2009; 15: 1142 – 1148.en_US
dc.identifier.citedreferenceLevine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6: 1228 – 1242.en_US
dc.identifier.citedreferenceDickinson DM, Bryant PC, Williams MC, et al. Transplant data: Sources, collection and caveats. Am J Transplant 2004;( Suppl 9 ): 13 – 26.en_US
dc.identifier.citedreferenceKalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data, 2nd Ed. New York: Wiley, 2002.en_US
dc.identifier.citedreferencePutter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi‐state models. Stat Med 2007; 26: 2389 – 2430.en_US
dc.identifier.citedreferenceA comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331: 1110 – 1115.en_US
dc.identifier.citedreferenceGonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361 – 365.en_US
dc.identifier.citedreferenceNair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179 – 1185.en_US
dc.identifier.citedreferenceCampbell MS, Kotlyar DS, Brensinger CM, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005; 11: 1048 – 1055.en_US
dc.identifier.citedreferenceBahirwani R, Campbell MS, Siropaides T, et al. Transplantation: Impact of pretransplant renal insufficiency. Liver Transpl 2008; 14: 665 – 671.en_US
dc.identifier.citedreferenceBerg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998–2007. Am J Transplant 2009; 9: 907 – 931.en_US
dc.identifier.citedreferenceRakela J, Vargas HE. Hepatitis C: Magnitude of the problem. Liver Transpl 2002; 8: S3 – S6.en_US
dc.identifier.citedreferenceFeng S, Goodrich NP, Bragg‐Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783 – 790.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2011.03703.x.pdf
Size:
128.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.